Nuclear preservation and cytoplasmic degradation of human immunodeficiency virus type 1 Rev protein

Journal of Virology

Volumn 70, Issue 2, 1996, Pages 1282-1287

  Kubota, Satoshi ^a   Duan, Lingxun ^a   Furuta, Rika A ^b   Hatanaka, Masakazu ^b,d   Pomerantz, Roger J ^a,c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c Division of Infectious Diseases   (United States)

^d SHIONOGI AND CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

REV PROTEIN;

ANIMAL CELL; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRACELLULAR TRANSPORT; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; VIRUS GENE;

EID: 0030040353     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.2.1282-1287.1996     Document Type: Article

References (28)

1. Adachi, Y., T. D. Copeland, C. Takahashi, T. Nosaka, A. Ahmed, S. Oroszlan, and M. Hatanaka. 1992. Phosphorylation of the Rex protein of human T-cell leukemia virus type I. J Biol. Chem. 267:21977-21981.
2. Cochrane, A. W., C.-H. Chen, and C. A. Rosen. 1990. Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to function. J. Virol. 64:881-885.
3. Cullen, B. R. 1987. Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 152:684-704.
4. Duan, L.-X., O. Bagasra, M. A. Laughlin, J. W. Oakes, and R. J. Pomerantz. 1994. Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. Proc. Natl. Acad Sci. USA 91:5075-5079.
5. Duan, L.-X., H. Zhang, J. W. Oakes, O. Bagasra, and R. J. Pomerantz. 1994. Molecular and virological effects of intracellular anti-rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains. Hum Gene Ther 5:1315-1324.
6. Fischer, U., S. Meyer, M. Teufel, C. Heckel, R. Luhrman, and G. Rautmann. 1994. Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA. EMBO J. 13:4105-4112
7. Furuta, R. A., S. Kubota, M. Maki, Y. Miyazaki, T. Hattori, and M. Hatanaka. 1995. Use of a human immunodeficiency virus type 1 Rev mutant without nucleolar dysfunction as a candidate for potential AIDS therapy. J. Virol 69:1591-1599.
8. Heaphy, S., J. T. Finch, M. J. Gait, J. Karn, and M. Singh. 1991. Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs. Proc Natl. Acad. Sci. USA 88:7366-7370.
9. Kalland, K.-H., A. M. Szilay, K. A. Brokstad, W. Saerevik, and G. Haukenes. 1994. The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments. Mol. Cell Biol. 14:7436-7444
10. Kubota, S., R. Furuta, M. Maki, and M. Hatanaka. 1992. Inhibition of human immunodeficiency virus type 1 Rev function by a mutant which interferes with nuclear/nucleolar localization of Rev. J. Virol. 66:2510-2513.
11. Kubota, S., T. Nosaka, B. R. Cullen, M. Maki, and M. Hatanaka. 1991. Effects of chimeric mutants of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type 1 Rex on nucleolar targeting signals. J. Virol. 65:2452-2456.
12. Kubota, S., H. Siomi, T. Satoh, S. Endo, M. Maki, and M. Hatanaka. 1989. Functional similarity of HIV-I rev and HTLV-I rex proteins: identification of a new nucleolar-targeting signal in rev protein. Biochem Biophys. Res. Commun 162:963-970.
13. Malim, M. H., S. Böhnlein, J. Hauber, and B. R. Cullen. 1989. Functional dissection of the HIV-1 Rev trans-activator - derivation of a trans-dominant repressor of Rev function. Cell 58:205-214.
14. Malim, M. H., and B. R. Cullen. 1991. HIV-1 structural gene expression requires binding of multiple Rev monomers of the RRE. implication for latency Cell 63:241-248.
15. Malim, M. H., and B. R. Cullen. 1993. Rev and the fate of pre-mRNA in the nucleus implications for the regulation of RNA processing in eukaryotes. Mol. Cell. Biol. 13:6180-6189.
16. Malim, M. H., W. W. Freimuth, J. Liu, T. J. Boyle, H. K. Lyerly, B. R. Cullen, and G. J. Nabel. 1992. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J. Exp. Med 176:1197-1201.
17. Malim, M. H., J. Hauber, S.-H. Le, J. V. Maizel, and B. R. Cullen. 1989. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (London) 338:254-257.
18. Malim, M. H., D. F. McCarn, L. S. Tiley, and B. R. Cullen. 1991. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J. Virol. 65:4248-4254.
19. Meyer, B. E., and M. H. Malim. 1994. The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes Dev. 8:1538-1547.
20. Miyazaki, Y., T. Takamatsu, T. Nosaka, S. Fujita, T. E. Martin, and M. Hatanaka. 1995 The cytotoxicity of human immunodeficiency virus type 1 Rev: implications for its interaction with the nucleolar protein B23. Exp. Cell Res. 219:93-101
21. Neumann, M., B. K. Felber, A. Kleinschmidt, B. Froese, V. Erfle, G. N. Pavlakis, and R. Brack-Werner. 1995. Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J. Virol. 69:2159-2167.
22. Nosaka, T., T. Takamatsu, V. Miyazaki, K. Sano, A. Sato, S. Kubota, M. Sakurai, Y. Ariumi, M. Nakai, S. Fujita, and M. Hatanaka. 1993. Cytotoxic activity of rev protein of human immunodeficiency virus type 1 by nucleolar dysfunction. Exp. Cell Res. 209:89-102.
23. Pomerantz, R. J., T. Seshamma, and D. Trono. 1992. Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency J. Virol. 66:1809-1813.
24. Richard, N., S. Iacampo, and A. Cochrane. 1994. HIV-1 Rev is capable of shuttling between the nucleus and cytoplasm. Virology 204:123-131.
25. Sakurai, M., S. Yamaoka, T. Nosaka, M. Akayama, A. Tanaka, M. Maki, and M. Hatanaka. 1992 Transforming activity and the level of Tax protein: effect of one point mutation in HTLV-1 Tax gene Int J. Cancer 52:323-328
26. Terwilliger, E., R. Burghoff, R. Sia, J. G. Sodroski, W. A. Haseltine, and C. Rosen, 1988. The art gene product of human immunodeficiency virus is required for replication J. Virol. 62:655-658.
27. Wolff, B., G. Cohen, J. Hauber, D. Meshcheryakova, and C. Rabeck. 1995. Nucleocytoplasmic transport of the Rev protein of human immunodeficiency virus type 1 is dependent on the activation domain of the protein. Exp Cell Res 217:31-41.
28. Zapp, M. L., and M. R. Green. 1989. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature (London) 342:714-716.